Form 8-K - Current report:
SEC Accession No. 0001437749-24-025872
Filing Date
2024-08-09
Accepted
2024-08-09 16:13:12
Documents
16
Period of Report
2024-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20240520_8k.htm   iXBRL 8-K 25449
2 EXHIBIT 99.1 ex_677271.htm EX-99.1 94458
7 atxilogo.jpg GRAPHIC 15219
  Complete submission text file 0001437749-24-025872.txt   277927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240809.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240809_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240809_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240809_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240520_8k_htm.xml XML 2847
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 241192924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)